IL231756B - Peptides with a fixed pattern as 1fpr inhibitors - Google Patents

Peptides with a fixed pattern as 1fpr inhibitors

Info

Publication number
IL231756B
IL231756B IL231756A IL23175614A IL231756B IL 231756 B IL231756 B IL 231756B IL 231756 A IL231756 A IL 231756A IL 23175614 A IL23175614 A IL 23175614A IL 231756 B IL231756 B IL 231756B
Authority
IL
Israel
Prior art keywords
fpr1
inhibitors
template
fixed peptidomimetics
peptidomimetics
Prior art date
Application number
IL231756A
Other languages
English (en)
Hebrew (he)
Other versions
IL231756A0 (en
Original Assignee
Polyphor Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polyphor Ag filed Critical Polyphor Ag
Publication of IL231756A0 publication Critical patent/IL231756A0/en
Publication of IL231756B publication Critical patent/IL231756B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL231756A 2011-10-07 2014-03-27 Peptides with a fixed pattern as 1fpr inhibitors IL231756B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11008121 2011-10-07
PCT/EP2012/069412 WO2013050346A1 (en) 2011-10-07 2012-10-02 Template -fixed peptidomimetics as inhibitors of fpr1

Publications (2)

Publication Number Publication Date
IL231756A0 IL231756A0 (en) 2014-05-28
IL231756B true IL231756B (en) 2019-06-30

Family

ID=46970289

Family Applications (1)

Application Number Title Priority Date Filing Date
IL231756A IL231756B (en) 2011-10-07 2014-03-27 Peptides with a fixed pattern as 1fpr inhibitors

Country Status (11)

Country Link
US (1) US9957297B2 (enExample)
EP (1) EP2764010B9 (enExample)
JP (1) JP6294227B2 (enExample)
CN (1) CN103842373B (enExample)
AU (2) AU2012320674A1 (enExample)
CA (1) CA2848584C (enExample)
ES (1) ES2576959T3 (enExample)
IL (1) IL231756B (enExample)
MX (1) MX349788B (enExample)
SG (1) SG11201400354PA (enExample)
WO (1) WO2013050346A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009008843A (es) 2007-02-28 2009-08-28 Polyphor Ltd Peptidomimeticos fijados a un patron.
US10654897B2 (en) * 2014-09-30 2020-05-19 Polyphor Ag β-hairpin peptidomimetics
US10259847B2 (en) 2014-09-30 2019-04-16 Polyphor Ag Beta-hairpin peptidomimetics
US10829520B2 (en) * 2015-03-23 2020-11-10 Polyphor Ag Beta-hairpin peptidomimetics
CA3032885C (en) * 2016-09-06 2023-06-20 Mainline Biosciences Cxcr4 antagonists and methods of use
CN112094316B (zh) * 2017-06-29 2022-04-08 安徽省农业科学院农产品加工研究所 一种Ser和Cys分列在两端的高锌螯合活性锌鳌合肽及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7253146B2 (en) 2001-02-23 2007-08-07 Polyphor Ltd Template-fixed peptidomimetics with antimicrobial activity
AU2002342618C1 (en) * 2002-08-20 2008-10-30 Polyphor Ltd. Template-fixed peptidomimetics with antibacterial activity
AU2003232253A1 (en) 2003-05-02 2004-11-23 Polyphor Ag Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
US7671028B2 (en) * 2004-02-04 2010-03-02 Postech Foundation Peptides that antagonize FPR class receptor mediated signaling
EP1879911B1 (en) 2005-05-02 2011-08-17 Polyphor Ltd. Dye conjugates of template-fixed peptidomimetics
MX2009008843A (es) * 2007-02-28 2009-08-28 Polyphor Ltd Peptidomimeticos fijados a un patron.
US8883720B2 (en) 2008-11-26 2014-11-11 Polyphor Ag Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity
US8865656B2 (en) * 2009-05-07 2014-10-21 Polyphor Ag Beta-hairpin peptidomimetics having CXCR4 antagonizing activity
EP2438047B1 (en) * 2009-06-02 2014-07-30 Nikan Pharmaceuticals, LLC Antagonism of human formyl peptide receptor for treatment of disease
WO2011066869A1 (en) * 2009-12-04 2011-06-09 Polyphor Ag Beta-hairpin peptidomimetics

Also Published As

Publication number Publication date
CA2848584A1 (en) 2013-04-11
CA2848584C (en) 2020-03-24
CN103842373B (zh) 2018-12-21
AU2017204122A1 (en) 2017-07-06
JP2014528958A (ja) 2014-10-30
EP2764010B1 (en) 2016-03-16
MX2014003960A (es) 2014-05-14
AU2012320674A1 (en) 2014-03-20
JP6294227B2 (ja) 2018-03-14
IL231756A0 (en) 2014-05-28
US9957297B2 (en) 2018-05-01
MX349788B (es) 2017-08-11
CN103842373A (zh) 2014-06-04
EP2764010A1 (en) 2014-08-13
ES2576959T9 (es) 2017-05-29
EP2764010B9 (en) 2017-01-18
ES2576959T3 (es) 2016-07-12
WO2013050346A1 (en) 2013-04-11
NZ621974A (en) 2015-06-26
SG11201400354PA (en) 2014-09-26
AU2017204122B2 (en) 2019-05-02
US20140287986A1 (en) 2014-09-25

Similar Documents

Publication Publication Date Title
EP2665724A4 (en) BICYCLIC ALK HEMMER
EP2683693A4 (en) ROR-GAMMA-T INHIBITORS
ZA201206456B (en) Uses of dgati inhibitors
ZA201309561B (en) Novel inhibitor compounds of phosphodiestarase type 10a
ZA201400232B (en) Metalloenzyme inhibitor compounds
ZA201306221B (en) Compounds and compositions as trk inhibitors
EP2723731A4 (en) COMPOUNDS INHIBITING METALLOENZYMES
EP2678018A4 (en) COMBINATION OF CHINESE HEMMER AND USES THEREOF
ZA201306580B (en) Cyclopropylamines as lsd1 inhibitors
LT2788343T (lt) Metalo fermentus slopinantys junginiai
ZA201300004B (en) Cyrstalline form of benzylbenzene sglt2 inhibitor
IL218018A0 (en) Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions
SMT201600001B (it) Imidazopiridazine come inibitori di akt chinasi
PT2670401E (pt) Métodos de utilização de inibidores de alk
ZA201308947B (en) Substituted pyridopyrazines as novel syk inhibitors
SG11201400102WA (en) Inhibitors of nedd8-activating enzyme
IL231352A0 (en) New enzyme inhibitory compounds
IL231353A0 (en) New enzyme inhibitory compounds
IL231756A0 (en) Peptides with a fixed pattern as 1fpr inhibitors
EP2629616A4 (en) SUBSTITUTED AMINO-TRIAZOLYL-PDE10-HEMMER
EP2751117A4 (en) METALLOENZYMHEMMERVERBINDUNGEN
EP2755663A4 (en) MicroRNA Inhibitors
LU91725B1 (en) Novel uses of V-ATPASE inhibitors
GB201104399D0 (en) Novel inhibitors
GB201120474D0 (en) Inhibitors

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed